Evidence map›Paper›PMID 38167744›Full record

ArticleNPJ Parkinson's disease2024

Aggregate-prone brain regions in Parkinson's disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility.

James A Wiseman, Helen C Murray, Richard L M F Faull, Michael Dragunow, Clinton P Turner, Birger Victor Dieriks, Maurice A Curtis

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
25.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Microorganisms · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

James A WisemanDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand. j.wiseman@auckland.ac.nz.ORCID http://orcid.org/0000-0001-9880-1612
Helen C MurrayDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0001-8707-7657
Richard L M F FaullDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
Michael DragunowCentre for Brain Research, University of Auckland, Auckland, 1023, New Zealand.ORCID http://orcid.org/0000-0003-1711-1631
Clinton P TurnerLabPlus, Department of Anatomical Pathology, Te Whatu Ora, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-2138-7633
Birger Victor DieriksDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-9392-3327
Maurice A CurtisDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand. m.curtis@auckland.ac.nz.ORCID http://orcid.org/0000-0003-4496-0233
University of Auckland · NZ

Funding

Manatu Hauora | Health Research Council of New Zealand (HRC) 21/034Manatu Hauora | Health Research Council of New Zealand (HRC) 21/710Neurological Foundation of New Zealand 1951 MSNeurological Foundation of New Zealand 2026 PRG
6 · The paper itself

Abstract

In Parkinson's disease (PD), and other α-synucleinopathies, α-synuclein (α-Syn) aggregates form a myriad of conformational and truncational variants. Most antibodies used to detect and quantify α-Syn in the human brain target epitopes within the C-terminus (residues 96-140) of the 140 amino acid protein and may fail to capture the diversity of α-Syn variants present in PD. We sought to investigate the heterogeneity of α-Syn conformations and aggregation states in the PD human brain by labelling with multiple antibodies that detect epitopes along the entire length of α-Syn. We used multiplex immunohistochemistry to simultaneously immunolabel tissue sections with antibodies mapping the three structural domains of α-Syn. Discrete epitope-specific immunoreactivities were visualised and quantified in the olfactory bulb, medulla, substantia nigra, hippocampus, entorhinal cortex, middle temporal gyrus, and middle frontal gyrus of ten PD cases, and the middle temporal gyrus of 23 PD, and 24 neurologically normal cases. Distinct Lewy neurite and Lewy body aggregate morphologies were detected across all interrogated regions/cases. Lewy neurites were the most prominent in the olfactory bulb and hippocampus, while the substantia nigra, medulla and cortical regions showed a mixture of Lewy neurites and Lewy bodies. Importantly, unique N-terminus immunoreactivity revealed previously uncharacterised populations of (1) perinuclear, (2) glial (microglial and astrocytic), and (3) neuronal lysosomal α-Syn aggregates. These epitope-specific N-terminus immunoreactive aggregate populations were susceptible to proteolysis via time-dependent proteinase K digestion, suggesting a less stable oligomeric aggregation state. Our identification of unique N-terminus immunoreactive α-Syn aggregates adds to the emerging paradigm that α-Syn pathology is more abundant and complex in human brains with PD than previously realised. Our findings highlight that labelling multiple regions of the α-Syn protein is necessary to investigate the full spectrum of α-Syn pathology and prompt further investigation into the functional role of these N-terminus polymorphs.

Identifiers

PMID38167744
PMCPMC10762179
OpenAlexW4390501473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.